Saltar al contenido
Merck

NF-κB inhibition rescues cardiac function by remodeling calcium genes in a Duchenne muscular dystrophy model.

Nature communications (2018-08-26)
Jennifer M Peterson, David J Wang, Vikram Shettigar, Steve R Roof, Benjamin D Canan, Nadine Bakkar, Jonathan Shintaku, Jin-Mo Gu, Sean C Little, Nivedita M Ratnam, Priya Londhe, Leina Lu, Christopher E Gaw, Jennifer M Petrosino, Sandya Liyanarachchi, Huating Wang, Paul M L Janssen, Jonathan P Davis, Mark T Ziolo, Sudarshana M Sharma, Denis C Guttridge
RESUMEN

Duchenne muscular dystrophy (DMD) is a neuromuscular disorder causing progressive muscle degeneration. Although cardiomyopathy is a leading mortality cause in DMD patients, the mechanisms underlying heart failure are not well understood. Previously, we showed that NF-κB exacerbates DMD skeletal muscle pathology by promoting inflammation and impairing new muscle growth. Here, we show that NF-κB is activated in murine dystrophic (mdx) hearts, and that cardiomyocyte ablation of NF-κB rescues cardiac function. This physiological improvement is associated with a signature of upregulated calcium genes, coinciding with global enrichment of permissive H3K27 acetylation chromatin marks and depletion of the transcriptional repressors CCCTC-binding factor, SIN3 transcription regulator family member A, and histone deacetylase 1. In this respect, in DMD hearts, NF-κB acts differently from its established role as a transcriptional activator, instead promoting global changes in the chromatin landscape to regulate calcium genes and cardiac function.